Tackling the neuropathic cough of idiopathic pulmonary fibrosis (IPF): more needs to be done
File(s)
Accepted version
Author(s)
Type
Journal Article
Abstract
Up to 80% of patients with idiopathic pulmonary fibrosis (IPF) suffer from a chronic cough, which may be the first symptom of the disease. Cough has been reported to be an independent predictor of disease progression [1] and is associated with reduced quality of life (QoL), because from the patients’ point of view, it causes physical and emotional distress with chest pain, hoarse voice, incontinence, and sleep disturbance [2, 3]. In addition, cough QoL scores have been independently associated with a higher risk of hospitalisation, lung transplantation and death at 1 year [4]. Therefore, control of cough in IPF remains an important priority.
Date Issued
2022-11-08
Date Acceptance
2022-11-02
Citation
Lung: an international journal on lungs, airways and breathing, 2022, 200 (6), pp.673-675
ISSN
0341-2040
Publisher
Springer
Start Page
673
End Page
675
Journal / Book Title
Lung: an international journal on lungs, airways and breathing
Volume
200
Issue
6
Copyright Statement
© 2022, The Author(s), under exclusive licence to Springer Science Business Media, LLC, part of Springer Nature.
Identifier
https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000880269900002&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
Subjects
Science & Technology
Life Sciences & Biomedicine
Respiratory System
CLINICAL-PRACTICE
CHEST GUIDELINE
DOUBLE-BLIND
MULTICENTER
MANAGEMENT
THERAPY
SPEECH
TRIAL
Publication Status
Published